Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes

Documenti analoghi

• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  di: Steinstraesser, A, et al.
  Pubblicazione: (2014)
• Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
  di: Ritzel, R, et al.
  Pubblicazione: (2015)
• Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1‐year patient‐level meta‐analysis of the EDITION clinical studies in people with type 2 diabetes
  di: Ritzel, Robert, et al.
  Pubblicazione: (2017)
• Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
  di: Klonoff, David, et al.
  Pubblicazione: (2015)
• Low within- and between-day variability in exposure to new insulin glargine 300 U/ml
  di: Becker, R H A, et al.
  Pubblicazione: (2015)